Citation Tools
Therapeutics
Rosiglitazone was non-inferior to metformin plus sulphonylurea for CV events but increased risk of HF and fractures in type 2 diabetes
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Rosiglitazone was non-inferior to metformin plus sulphonylurea for CV events but increased risk of HF and fractures in type 2 diabetes